Device Trial Radar · NCT07260578
Safety and Efficacy of Ellacor® Micro-coring® Following Best Practices on Technique and Post-Procedural Care
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Nov 26, 2025
Primary completion
Mar 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Cytrellis Biosystems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 3, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Since its inception of being marketed in the United States in 2021, physicians have used various post procedure skin care regimen to facilitate recovery. This study aims to examine the use of three post care products in five skin care regimens
Conditions
- Best Practices
- Ellacor
- Micro-coring Post Care
- Ellacor Post Care
Interventions
ellacor Micro-Coring TechnologyDevice
ellacor will be used to treat moderate-severe wrinkles in the mid to lower face in subjects aged between 45-65.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Global Aesthetic Improvement Scale (GAIS)Time frame: GAIS Assessment will be performed under a timeframe of 90 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Miami Dermatology And Laser Institute
Miami, Florida
Caloaesthetics Plastic Surgery Center
Louisville, Kentucky
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.